Economic Evaluations of Imaging Biomarker-Driven Companion Diagnostics for Cancer: A Systematic Review.
Sibo LiuDaniel Shao-Weng TanNicholas GravesAnn-Marie ChackoPublished in: Applied health economics and health policy (2023)
Despite favorable results towards the implementation of imaging biomarker-based CDx for cancer, there is room for improvement regarding the quantity and quality of economic evaluations, and that is expected as the awareness of current study limitations increases and more clinical data become available in the future.